Cargando…
Mitochondria in Cell-Based Therapy for Stroke
Despite a relatively developed understanding of the pathophysiology underlying primary and secondary mechanisms of cell death after ischemic injury, there are few established treatments to improve stroke prognoses. A major contributor to secondary cell death is mitochondrial dysfunction. Recent adva...
Autores principales: | Monsour, Molly, Gordon, Jonah, Lockard, Gavin, Alayli, Adam, Borlongan, Cesar V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854436/ https://www.ncbi.nlm.nih.gov/pubmed/36671040 http://dx.doi.org/10.3390/antiox12010178 |
Ejemplares similares
-
Minor Changes for a Major Impact: A Review of Epigenetic Modifications in Cell-Based Therapies for Stroke
por: Monsour, Molly, et al.
Publicado: (2022) -
The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
por: Gordon, Jonah, et al.
Publicado: (2022) -
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation
por: Lockard, Gavin Miles, et al.
Publicado: (2022) -
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
por: Gordon, Jonah, et al.
Publicado: (2022) -
Stem Cells Attenuate the Inflammation Crosstalk Between Ischemic Stroke and Multiple Sclerosis: A Review
por: Monsour, Molly, et al.
Publicado: (2023)